Duloxetine versus placebo for the treatment of Korean women with stress predominant urinary incontinence

Korean Journal of Urology

Volumn 47, Issue 5, 2006, Pages 527-535

  Mah, Sang Yol ^a   Lee, Kyu Sung ^b   Choo, Myung Soo ^c   Seo, Ju Tae ^d   Lee, Jeong Zoo ^e   Park, Won Hee ^f   Kim, Joon Chul ^g   Lee, Seung Yun ^h   Zhao, Yan Daniel ⁱ   Beyrer, Julie ⁱ   Wulster Radcliffe, Meghan ⁱ   Levine, Louise ⁱ   Viktrup, Lars ⁱ  

^a Yonsei University College of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Asan Medical Center   (South Korea)

^d Samsung Advanced Institute of Technology (SAIT)   (South Korea)

^e Pusan National University Hospital   (South Korea)

^f Inha University Hospital   (South Korea)

^g The Catholic University of Korea   (South Korea)

^h Lilly Korea   (South Korea)

ⁱ ELI LILLY AND COMPANY   (United States)

Author keywords

Duloxetine; Stress; Urinary incontinence

Indexed keywords

DULOXETINE; PLACEBO;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; ATTENTION DISTURBANCE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; FATIGUE; FEMALE; HEADACHE; HUMAN; KOREA; LABORATORY TEST; LETHARGY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; PARALLEL DESIGN; PHASE 3 CLINICAL TRIAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SOMNOLENCE; STATISTICAL SIGNIFICANCE; STRESS INCONTINENCE; VITAL SIGN; XEROSTOMIA;

EID: 33746385421     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2006.47.5.527     Document Type: Article

References (27)

1. Abrams P, Cardozo L, Khoury S, Wein A. International Consultation on Incontinence. 3rd ed. Plymouth: Health Publication Ltd; 2005
2. Oh SJ, Park WH, Park CH, Paick JS, Seo JT, Lee YS, et al. Prevalence of urinary incontinence and incontinence-related quality of life in Korean women: a population-based study. J Korean Continence Soc 2003;7:73-80
3. Chen GD, Lin TL, Hu SW, Chen YC, Lin LY. Prevalence and correlation of urinary incontinence and overactive bladder in Taiwanese women. Neurourol Urodyn 2003;22:109-17
4. Ju CC, Swan LK, Merriman A, Choon TE, Viegas O. Urinary incontinence among the elderly people of Singapore. Age Ageing 1991;20:262-6
5. Ma SS. The prevalence of adult female urinary incontinence in Hong Kong Chinese. Int Urogynecol J Pelvic Floor Dysfunct 1997;8:327-31
6. Yu HJ, Chen J, Lai MK, Chan KA, Chie WC. High prevalence of voiding symptoms in Taiwanese women. Br J Urol 1998; 82:520-3
7. Minassian VA, Drutz HP, Al Badr A. Urinary incontinence as a worldwide problem. Int J Gynaecol Obstet 2003;82:327-38
8. Ueda T, Tamaki M, Kageyama S, Yoshimura N, Yoshida O. Urinary incontinence among community-dwelling people aged 40 years or older in Japan: prevalence, risk factors, knowledge and self-perception. Int J Urol 2000;7:95-103
9. Fultz NH, Burgio K, Diokno AC, Kinchen KS, Obenchain R, Bump RC. Burden of stress urinary incontinence for community-dwelling women. Am J Obstet Gynecol 2003;189:1275-82
10. Kinchen KS, Burgio K, Diokno AC, Fultz NH, Bump R, Obenchain R. Factors associated with women's decisions to seek treatment for urinary incontinence. J Womens Health 2003;12:687-98
11. Thor KB, Katofiasc MA. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. J Pharmacol Exp Ther 1995;274: 1014-24
12. Norton PA, Zinner NR, Yalcin I, Bump RC. Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 2002;187:40-8
13. Dmochowski RR, Miklos JR, Norton PA, Zinner NR, Yalcin I, Bump RC. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol 2003;170:1259-63
14. van Kerrebroeck P, Abrams P, Lange R, Slack M, Wyndaele JJ, Yalcin I, et al. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. BJOG 2004;111:249-57
15. Millard RJ, Moore K, Rencken R, Yalcin I, Bump RC. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial. BJU Int 2004;93:311-8
16. Wyman JF, Fantl JA, McClish DK, Bump RC. Comparative efficacy of behavioral interventions in the management of female urinary incontinence. Continence Program for Women Research Group. Am J Obstet Gynecol 1998;179:999-1007
17. Kondo A, Yokoyama E, Koshiba K, Fukui J, Gotoh M, Yoshikawa Y, et al. Bladder neck support prosthesis: a nonoperative treatment for stress or mixed urinary incontinence. J Urol 1997;157:824-7
18. Bodell DM, Leach GE. Needle suspension procedures for female incontinence. Urol Clin North Am 2002;29:575-84
19. Rodriguez LV, Raz S. Prospective analysis of patients treated with a distal urethral polypropylene sling for symptoms of stress urinary incontinence: surgical outcome and satisfaction determined by patient driven questionnaires. J Urol 2003;170: 857-63
20. Patrick DL, Martin ML, Bushnell DM, Yalcin I, Wagner TH, Buesching DP. Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QoL). Urology 1999;53:71-6
21. Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 2003;189: 98-101
22. Os SJ, Park HG, Lim SH, Hong SK, Martin ML, Ting BL, et al. Translation and linguistic validation of Korean version of the incontinence quality of life (I-QoL) instrument. J Korean Continence Soc 2002;6:10-23
23. Cardozo L, Drutz HP, Baygani SK, Bump RC. Pharmacological treatment of women awaiting surgery for stress urinary incontinence. Obstet Gynecol 2004;104:511-9
24. Komaroff AL, Fagioli LR, Doolittle TH, Gandek B, Gleit MA, Guerriero RT, et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med 1996;101:281-90
25. Lenderking WR, Nackley JF, Anderson RB, Testa MA. A review of the quality-of-life aspects of urinary urge incontinence. Pharmacoeconomics 1996;9:11-23
26. Bump R, Yalcin I, Voss S. The effect of duloxetine dose escalation and tapering on the incidence of adverse events (Ae) in women with stress urinary incontinence. Int Continence Soc 2005
27. Yalcin I, Bump RC. The effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinence. Am J Obstet Gynecol 2004;191: 194-7